Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Mainz researchers identify novel factor involved in autophagy

12.02.2015

Insight may enable innovative approach for new concepts in the fight against neurodegenerative diseases

Neurodegenerative disorders such as Alzheimer's disease are typically characterized by protein deposits in the brain. These are comprised of defective, insoluble proteins which no longer fulfill their function and which cells are unable to break down.


The transparent nematode C. elegans, only 1 millimeter in length, has characteristics which include a short life cycle and a fixed number of cells. It serves as a model organism primarily for research in developmental biology, genetics, and neurobiology.

source: Dr. Andreas Kern, Mainz University Medical Center

The work group headed by Professor Christian Behl of the Institute of Pathobiochemistry of the University Medical Center of Johannes Gutenberg University Mainz has determined the RAB3GAP complex as a novel factor that influences the efficient degradation of proteins. The researchers were able to show that the complex plays an important role in autophagy, a physiological process that breaks down cellular proteins and organelles.

This insight opens up possible new options for the development of therapeutic and preventative approaches for neurodegenerative diseases. The work group has published the results of their research in the specialized journal Autophagy.

The team led by Professor Christian Behl and Dr. Andreas Kern showed that the RAB3GAP complex has a decisive influence on the process of protein degradation and represents an important element of the cellular autophagy network. Autophagy is a process in which cells digest their own components. These could be excessive or damaged organelles, such as mitochondria, invading pathogens, such as viruses or bacteria, or cytoplasmic macromolecules.

Autophagy serves on the one hand for the recycling of the building blocks of cells and the provision of energy, but is also activated specifically in stress situations. "The controlled protein degradation by autophagy is a core aspect of protein homoeostasis, which means the complex interplay between the formation, folding, and decomposition of proteins. We have extended our understanding of age-related disorders by identifying new factors involved in this process," said Professor Christian Behl.

The research group discovered that the RAB3GAP complex promotes the formation of autophagic vesicles. These are bubble-like structures with a lipid shell that envelop the substrates to be degraded. The autophagic vesicles then fuse with lysosomes, simple cell organelles, which contain digestive enzymes that break down the substrates into their component parts.

"The autophagic vesicles need lipid membranes to form, and the cell has to provide those. Our discovery suggests that RAB3GAP recruits the lipids required for the autophagic degradation of proteins," explained Dr. Andreas Kern of the Institute of Pathobiochemistry, who was responsible for the experiments.

It was previously known that the RAB3GAP complex is important for the regulation of the RAB GTPase RAB3, and that it influenced vesicle transport at the synapses, which are the contact points between nerve cells. The novel finding established that the complex indeed has a dual function, which is of particular relevance with regard to diseases of the nervous system.

The researchers made their discovery employing the nematode C. elegans, which serves as a simplified model, to study the human nervous system. In C. elegans, the biochemists were able to knock down approximately 2,500 individual genes using special molecular biological techniques and analyze the effects on protein aggregation. This allowed the identification of numerous genes that were associated with increased protein aggregation once they had been turned off. Subsequently, the precise functional characterization was completed using cultures of human cells.

The work group at the Institute of Pathobiochemistry was also able to demonstrate that the positive influence on autophagy by the RAB3GAP complex antagonizes that of a previously known negative autophagy regulator. "Our hypothesis is that it is the relative balance of the effects of these opposed molecules that determines the overall autophagic activity of cells. We believe that not only have we come closer to understand the autophagy process itself but also, and more importantly, that it may be possible to develop new approaches to the treatment and prevention of neurodegenerative diseases by means of targeted intervention in this process," stated Behl.

In addition to the Mainz-based team, biochemists from Goethe University Frankfurt am Main were also involved in the research project that stretched over several years. This received funding from a wide range of organizations, including the Alzheimer Forschung Initiative e.V., the German Research Foundation (DFG) – also within the framework of the Collaborative Research Center 1080: "Molecular and cellular mechanisms of neural homoeostasis" –, the European Research Council (ERC), and a number of foundations.

PUBLICATION:
Spang N., Feldmann A., Huesmann H., Bekbulat F., Schmitt V., Hiebel C., Koziollek-Drechsler I., Clement A.M., Moosmann B., Jung J., Behrends C., Dikic I., Kern A., Behl C., RAB3GAP1 and RAB3GAP2 modulate basal and rapamycin-induced autophagy. Autophagy 2014: 10(12):2297-309.
DOI:10.4161/15548627.2014.994359
http://www.tandfonline.com/doi/full/10.4161/15548627.2014.994359#tabModule

CONTACT:
Professor Dr. Christian Behl
Director of the Institute of Pathobiochemistry
University Medical Center of Johannes Gutenberg University Mainz
Duesbergweg 6, D 55099 Mainz – GERMANY
phone +49 6131 39-25890
fax +49 6131 39-25792
e-mail: cbehl@uni-mainz.de
http://www.unimedizin-mainz.de/pathobiochemie

Dr. Christine Ziegler
Institute of Pathobiochemistry
University Medical Center of Johannes Gutenberg University Mainz
Duesbergweg 6, D 55099 Mainz – GERMANY
Telefon +49 6131 39-24552
e-mail: christine.ziegler@uni-mainz.de
http://www.unimedizin-mainz.de/pathobiochemie

PRESS CONTACT:
Oliver Kreft, Press and Public Relations, Mainz University Medical Center
phone +49 6131 17-7424
fax +49 6131 17-3496
e-mail: pr@unimedizin-mainz.de
http://www.unimedizin-mainz.de/index.php?L=1

Weitere Informationen:

http://dx.doi.org/10.4161/15548627.2014.994359

Petra Giegerich | idw - Informationsdienst Wissenschaft

More articles from Health and Medicine:

nachricht PET imaging tracks Zika virus infection, disease progression in mouse model
20.09.2017 | US Army Medical Research Institute of Infectious Diseases

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Molecular Force Sensors

20.09.2017 | Life Sciences

Producing electricity during flight

20.09.2017 | Power and Electrical Engineering

Tiny lasers from a gallery of whispers

20.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>